Ultimately, this cycle drives advances to prevent diabetes and to help people burdened by it. Adafunded researchers use the money from their awards to conduct critical diabetes research. If you continue browsing the site, you agree to the use of cookies on this website. However, exposure to many triggers airborne viruses, tobacco smoke, pollution, indoor allergens, etc. Review risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention yanling wu 1,2,yanping ding,yoshimasa tanaka3 and wen zhang2 1. An evolving scientific basis for the prevention and treatment. The remainder of this article aims to provide an update for the general physician on some of these recent advances focussing on progress in i management of acute gout and ii longterm management options. The choice of therapies should be guided by the initial assessment of a patients degree of obesity and comorbid conditions, if present. In recent years, its prevalence has blow slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. Review risk factors contributing to type 2 diabetes and. Successful treatment of obesity usually requires multiple interventions. Erectile dysfunction ed is one of the most common conditions affecting middleaged and older men.
Below, we highlight some recent advances related to neurogenic hypertension, fitting these into this framework. Recent advances in the genetics of severe childhood obesity. Both thiazolidinediones and metformin have been shown to decrease insulin and androgen levels. However, most of the antiobesity drugs often show poor outcome for weightloss and cause severe adverse effects. Only after the technological advances of the eighteenth century did a gradual increase in food supply became available. Recent advances in the treatment of diabetic neuropathy. For this reason, new pharmacological alternatives are investigated.
Recent advancements in drug treatment of obesity ncbi. This paper discusses recent advances in the field of genetics of obesity with an emphasis on several established loci that influence obesity. A pharmacological target to decrease acylated ghrelin levels. The discovery of these genetic defects has biological and clinical implications which are greater than. A new paradigm for research and treatment of obesity ucla health.
Obesity is still widely decried as a lifestyle choice, but even determined changes in lifestyle have very limited longterm impact on it and, pragmatically, the need for medical intervention is now clear. Nearly every primary care physician, internist and geriatrician will be called upon to manage this condition or to make referrals to urologists, endocrinologists and cardiologists who will assist in the treatment of ed. Lab of molecular immunology, zhejiang provincial center for disease control and prevention, 3399 binsheng road, hangzhou, 310051, china. Diabetes is one of the most frequent prob lems associated with obesity, as explained in one chap ter. Request pdf recent advances in the treatment of childhood obesity the rapid increase in the prevalence of obesity in the last decade indicates a need for effective treatment programs. Recent advances on diagnosis and management of childhood.
Advances in the science, treatment, and prevention of the disease of obesity. The epidemic of childhood allergic disorders has been associated to the decline of infectious disease. Recent advances in clinical practice challenges and. The pattern of recent advances in the treatment of cancer differs somewhat from that of the past. Breast feeding practices, nutrition, dietary and obesity also play a multifaceted role in shaping the observed worldwide trends of childhood allergies. In particular, we focus on recent reports providing new insight into the neural mediation of hypertension associated with high dietary salt intake, obesity, and inflammatory states.
Chronic food shortage and malnutrition have been the scourge of humankind from the dawn of history. Three chapters are devoted to problems of the cardiovascular system and lipopro tein abnormalities, which are important consequences of obesity. The advances in obesity management curriculum is a series of evidencebased continuing medical education activities designed to educate endocrinologists, obgyns, primary care physicians, and other clinicians involved in the care of patients with obesity on the current evidence and practices in the management of obesity, including the mechanism of action, efficacy, safety, and tolerability of emerging pharmacotherapies for the treatment of obesity. Recent advances in the treatment of diabetes mellitus slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. Lifestyle modification remains the cornerstone of antiobesity treatment, but drugs can be introduced as adjuncts to assist and maintain weight loss. In spite of all the experimental and clinical work on diabetes which has been done in the past years, a specific or etiologic treatment has not been attained. The clinical advances in treating obesity as a chronic disease. Sharma mbbs department of pharmacology, maulana azad medical college and associated hospitals, new delhi, india. The involvement of ghrelin in obesity led to the development of several ghrelinrelated pharmacological tools for the treatment of obesity.
The initial effect of these advances in improved public health. A striking advance has been made in dietetic treatment, however, and, with the clearer and more detailed knowledge of the metabolic. Pharmacotherapeutic agents used to treat obesity include sympathomimetic appetite suppressant drugs, pancreatic lipase inhibitors, antidiabetic. Recent advances in chronic kidney disease articles elsevier. The recent appearance of beige or brownlike adipocytes in wat depots of adult humans has sparked interest to use thermogenic activity for obesity treatment 38, 45.
Novel insights and strategies curriculum provides education on the latest clinical trial results and therapeutic strategies for obesity management. More interestingly, increasing evidence indicates a potential relation between obesity and central nervous system disorders such as cognitive deficits. Recent advances in the development of vaccines for. Transduction mechanisms chemosensory transduction mechanismsthe processes that enable the conversion of detection into an electrical signalare employed widely throughout the body and are implicated in regulation of digestive5861 as well as respiratory functions. Pharmacological advances to the treatment of obesity journal of. A great progress has been made by the microelectronics industry since 1990, which is extremely beneficial for the microfabrication of microneedle. The 7th conference will focus on a range of topics that impact the prevention and treatment of obesity beyond the clinic setting, considering the broader social and environmental factors that influence the health of children. At present, the lipase inhibitor orlistat xenical is the only ukapproved long term medical therapy for obesity. It represents, perhaps, an indication of a new trend, long foreseen, toward more radical surgery on the one hand and toward new biochemical approaches on. Obesity is a condition in which excess fat has accumulated to the extent that health is adversely affected 1.
Vaccines are commonly used in the prevention of infectious diseases. Its growing impact on healthcare systems is becoming unsustainable and urgent advances in treatment are needed. Advances in the surgical treatment of obesity medscape mar 31, 2003. Thus, programs for weight maintenance are critical to ultimate. Based on these advances in the therapeutic area, we. The current worldwide epidemic of obesity, now recognized as a public health crisis, is barely a few decades old. Recent advances in the treatment of erectile dysfunction.
Another recent alternative to emerge for the surgical management of obesity is the adjustable gastric band technique. The future holds promise for a new drug that alone or in combination with an existing agent could target the initial pathophysiology and morbidities associated with obesity. Effective management of obesity mdedge family medicine. Persistently high obesity rates over the past decade underscore the need for. Advances in the surgical treatment of morbid obesity. In time, they publish their findings in order to inform fellow scientists of their results, which ensures that others will build upon their work. The advances in obesity management curriculum is a series of evidencebased continuing medical education activities designed to educate endocrinologists, obgyns, primary care physicians, and other clinicians involved in the care of patients with obesity on the current evidence and practices in the management of obesity, including the mechanism.
Recent advances in the pathophysiology and pharmacological treatment of obesity. Advances in the science, treatment, and prevention of the disease. The article concludes with discussion of future directives. Clinical highlights from the naaso 2003 annual meeting clinical diabetes. Citescore values are based on citation counts in a given year e. Obesity is a complex chronic disease that has become a major public health problem in many countries throughout the world because of its high prevalence, causal relationship with many serious medical illnesses, adverse effects on qualityoflife, and marked economic consequences related to increased health care costs and decreased productivity.
Obesity is one of the most common factor which underlies the pathophysiology of many other non communicable diseases. As obesity rates increase, so too do the risks of type 2 diabetes, cardiovascular disease, and numerous other detrimental conditions. The use of insulinsensitizing agents has been widely studied in pcos. Despite recent setbacks in the pharmacotherapy of obesity withdrawal of rimonabant and sibutramine, many compounds are in phase iiiii trials. More recently humanized monoclonal antibodies have been successfully used for the.
Recent advances in potential clinical application of. Recent advances in the pathophysiology and pharmacological. A history of obesity, or how what was good became ugly and. Recent advances and current trend in the pharmacotherapy of. Autoantigen or oligo vaccination has been used for disease animal models. Current treatment strategies for obesity katarina kos, christine baker. Abstracta survey of the literature dealing with recent advances in the treatment of peptic ulcer reveals a growing appreciation of the importance of the pathological physiology of this malady. Scientists may be just a few years away from making an artificial pancreas that can detect and adjust your blood sugar glucose levels. Topics include recent research into various diets for weight loss, the relationship between obesity and polycystic ovarian syndrome, and future treatments of obesity. In the past three years, five single gene disorders resulting in early onset obesity have been characterised. This has led to exploration of wat browning as a target for obesity treatment 39, 42, 43, 64. Recent findings there has been an increasing understanding of the pathogenesis of diabetic neuropathy in recent years, and new drugs that target the pathophysiological mechanisms are currently being studied.
Recent advances in the treatment of diabetes mellitus. Twin studies suggest a heritability of fat mass, and disorders of energy balance that arise from genetic defects have been identified. Advances in the science, treatment, and prevention of the disease of. Nanotechnology advances towards development of targeted. Advances in the science, treatment, and prevention of the. This may position vsg as an increasingly important procedure, particularly for the treatment of pediatric obesity. The basic principle of vaccination is to use specific antigens, endogenous or exogenous to stimulate immunity against the specific antigens or cells producing them. Although this trend may be leveling off, obesity and its individual, societal, and economic costs remain of grave concern.
Pdf recent advances in obesity research and management. Pharmacological treatment of obesity in pcos should specifically target the metabolic risks for diabetes and cvd. Recent advances in obesity research and management. We present data suggesting that vsg, albeit a newer procedure, may be as effective as rygb with fewer adverse effects including less surgical risk, reduced nutritional deficiency, and less incidence of dumping syndrome. Despite advances in understanding the roles of adiposity, food intake, gi and adipocyterelated hormones, inflammatory mediators, the gutbrain axis and the hypothalamic nervous system in the pathophysiology of obesity, the effects of different therapeutic interventions on those pathophysiological mechanisms are controversial. In comparison with other transdermal delivery methods, microneedles have been typically fabricated as much as a depth of 200. A variety of interventions can achieve shortterm weight loss, but rebound weight gain is common when therapy is stopped. In the various clinics and medical centers the gastroenterologists are forsaking rule of thumb treatment and are attempting to individualize each case. Pdf recent advancements in drug treatment of obesity. Review article recent advances in the pathophysiology and pharmacological treatment of obesity p.
1266 717 1029 716 948 170 607 377 628 634 1470 846 999 67 880 626 1073 994 787 2 729 7 1183 433 887 164 1485 845 1289